OVID icon

Ovid Therapeutics
OVID

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$3
46% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
LifeSci Capital
LifeSci Capital
100% 1-yr OVID win rate
22 Dec ‘25 2 months ago
HC Wainwright & Co
HC Wainwright & Co
Raghuram Selvaraju
75% 1-yr OVID win rate
22 Dec ‘25 2 months ago
Roth Capital
Roth Capital
Boobalan Pachaiyappan
100% 1-yr OVID win rate
11 Dec ‘25 2 months ago